ALS News
ALS Clinical Trials Actively Recruiting
ALS NEWS - August 05, 2020
ALS Crowd is dedicated to connecting researchers, doctors, patients, and caregivers/family members in order to support, educate, and find patterns in therapy to... Read More
Uncovering the Benefits of Riluzole for ALS Patients
ALS NEWS - August 01, 2020
Riluzole is the only FDA-approved drug therapy for ALS patients. The American Academy of Neurology recommends that Riluzole should be offered to ... Read More
New Breakthrough in Silencing ALS Gene SOD1
ALS NEWS - July 14, 2020
ALS is generally classified into two categories, familial or hereditary ALS and sporadic or non-hereditary ALS. Those with familial ALS (fALS) have mutations in... Read More
New Cells Discovered to be Involved in ALS
ALS NEWS - July 08, 2020
Brown University researchers identified specific cells (glial cells) within the nervous system cells as a potential source of decay in diseases like ALS. T... Read More
Pimozide May Provide Better Quality of Life for ALS patients
ALS NEWS - June 18, 2020
Pimozide is a drug currently being used to suppress the physical (motor) and vocal (phonic) symptoms of tics when these symptoms interfere with daily life ... Read More
Genetic Mutation Affecting Proteins Could Cause ALS
ALS NEWS - June 14, 2020
Over 5,000 people are diagnosed with ALS each year in the United States. Amyotrophic Lateral Sclerosis is a disease that attacks the very roots of hum... Read More
It is time to ACT against ALS!
ALS NEWS - June 10, 2020
Two pieces of legislation are making their way through congress that could drastically improve the lives of those with ALS. The first is a bill intended to... Read More
Microorganism Involvement in ALS Progression
ALS NEWS - May 31, 2020
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the motor neurons in the central nervous system. For years, researchers have bee... Read More
FDA Approves Masitinib for a Phase 3 ALS Clinical Trial
ALS NEWS - May 30, 2020
AB Science, a clinical stage pharmaceutical company, received clearance on their application to use masitinib in an upcoming 3 phase clinical trial to... Read More
FDA Gives Fast Track Status to New Drug for Potential ALS Treatment
ALS NEWS - May 27, 2020
After much research and several clinical trials on neurodegenerative diseases, good news comes from the FDA as they allow Fast Track Designation in the dev... Read More
Biomarkers in Teeth Associated with ALS
ALS NEWS - May 27, 2020
The mission to find biological markers in connection to ALS, or Amyotrophic Lateral Sclerosis is striving and thriving. A recent study has been conducted in the... Read More
$42 Million Invested in ALS Treatments
ALS NEWS - May 15, 2020
QurAlis, a corporation based in Massachusettes, Boston has invested $42 million toward the research and development of ALS treatments. This is such a ... Read More
ALS and COVID-19 Precautions
ALS NEWS - May 03, 2020
Living with ALS can prompt all sorts of questions regarding COVID-19. What is COVID-19? How do I protect myself? How do I protect my loved ones? ... Read More
